Inventor · disambiguated record
Florian Ruker
Also filed as: RUEKER FLORIAN · RUKER FLORIAN · RÜKER FLORIAN
15 granted patents·14 pending applications·220 citations·filing 1994–2023
93Inventor score
Files withF-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H7F STAR BIOTECH FORSCH & ENTW4F STAR THERAPEUTICS LTD4KATINGER HERMANN3MERCK PATENT GMBH3
Top patents by PatentIndex Score
29 records- 0192US9133274B2Method for engineering immunoglobulinsHIMMLER GOTTFRIED·Filed 2007·Granted Sep 15, 2015·16 cites·38 claims
- 0292US9045528B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsRUKER FLORIAN·Filed 2011·Granted Jun 2, 2015·21 cites·19 claims
- 0391US9651559B2Display of binding agentsF-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H·Filed 2014·Granted May 16, 2017·8 cites·9 claims
- 0491US8921279B2Display of binding agentsHIMMLER GOTTFRIED·Filed 2008·Granted Dec 30, 2014·13 cites·6 claims
- 0589US9856311B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsRUKER FLORIAN·Filed 2011·Granted Jan 2, 2018·12 cites·9 claims
- 0686US10385118B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR BIOTECHNOLOGISCHE FORSCHUNGS UND ENTW M B H·Filed 2017·Granted Aug 20, 2019·4 cites·6 claims
- 0785US5866694APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1997·Granted Feb 2, 1999·52 cites·18 claims
- 0881US2023340696A1Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0978US2024150495A1Novel Multivalent ImmunoglobulinsF STAR THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1074US5948609AOxygen-transporting albumin-based blood replacement composition and blood volume expanderFiled 1997·Granted Sep 7, 1999·41 cites·20 claims
- 1173US5756674APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1995·Granted May 26, 1998·31 cites·8 claims
- 1271US11084868B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR BIOTECHNOLOGISCHE FORSCHUNGS UND ENTW M B H·Filed 2019·Granted Aug 10, 2021·0 cites·7 claims
- 1370US11499249B2Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR THERAPEUTICS LTD·Filed 2019·Granted Nov 15, 2022·0 cites·13 claims
- 1470US2021388339A1Method for engineering immunoglobulinsF STAR BIOTECHNOLOGISCHE FORSCHUNGS UND ENTW M B H·Filed 2021·Application pending·0 cites
- 1565US5693752APeptides that induce antibodies which neutralize genetically divergent HIV-1 isolatesKATINGER HERMANN·Filed 1994·Granted Dec 2, 1997·22 cites·13 claims
- 1661US11827720B2Multivalent immunoglobulinsF STAR THERAPEUTICS LTD·Filed 2017·Granted Nov 28, 2023·0 cites·5 claims
- 1760US2017369868A1Method for engineering immunoglobulinsF-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H·Filed 2017·Application pending·0 cites
- 1857US2010009863A1Method for engineering t-cell receptorsF STAR BIOTECH FORSCH & ENTW·Filed 2007·Application pending·0 cites
- 1956US2013040836A1Methods for engineering t-cell receptorsSTAR BIOTECHNOLOGISCHE FORSCHUNGS UND ENTWICKLUNGSGES M B H F·Filed 2012·Application pending·0 cites
- 2056US2017247432A1Display of binding agentsF-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H·Filed 2017·Application pending·0 cites
- 2155US2017015727A1Methods for engineering t-cell receptorsF-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H·Filed 2016·Application pending·0 cites
- 2254US2009298195A1Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regionsF STAR BIOTECH FORSCH & ENTW·Filed 2006·Application pending·0 cites
- 2354US2010048877A1Novel multivalent immunoglobulinsF STAR BIOTECH FORSCH & ENTW·Filed 2007·Application pending·0 cites
- 2453US2015376603A1Method for engineering immunoglobulinsF STAR BIOTECH FORSCH & ENTW·Filed 2015·Application pending·0 cites
- 2552US2007041987A1Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine developmentCARTER DANIEL·Filed 2004·Application pending·0 cites
- 2644US11623963B2Cysteine engineered antigen-binding moleculesMERCK PATENT GMBH·Filed 2018·Granted Apr 11, 2023·0 cites·17 claims
- 2744US2019352429A1Preferred pairing of antibody domainsMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 2836US2012094874A1Stabilized immunoglobulin constant domainsRUEKER FLORIAN·Filed 2010·Application pending·0 cites
- 2930US10982008B2Domain-exchanged antibodyMERCK PATENT GMBH·Filed 2015·Granted Apr 20, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Florian Ruker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →